Large PBMs Balk at Push to Reduce Drug Prices
In a move that exemplifies the potential conflict of interest that some large pharmacy benefit managers have, the nation’s largest PBM earlier this year said it would demand that rebates remain unchanged when drug makers roll out new price cuts. Drug makers earlier in the year said they would start reducing prices as well as […]
Large PBMs Balk at Push to Reduce Drug Prices Read More »
